Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
摘要
The invention provides methods for predicting therapeutic responsiveness of a subject suffering from cognitive impairments or dysfunctions, psychotic and/or neurodegenerative disorders to an alpha 7 nicotinic acetylcholine receptor activator treatment.
申请公布号
AU2013356914(B2)
申请公布日期
2017.01.05
申请号
AU20130356914
申请日期
2013.12.09
申请人
Novartis AG
发明人
Feuerbach, Dominik;Gomez-Mancilla, Baltazar;He, Yunsheng;Johns, Donald;Lopez-Lopez, Cristina;McAllister, Kevin Hall;Pezous, Nicole;Sandford, Lisa;Weiss, Markus
